A detailed history of Leo Wealth, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Leo Wealth, LLC holds 5,600 shares of NVO stock, worth $594,328. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,600
Previous 5,756 2.71%
Holding current value
$594,328
Previous $827 Million 19.33%
% of portfolio
0.06%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$119.07 - $145.42 $18,574 - $22,685
-156 Reduced 2.71%
5,600 $667 Million
Q2 2024

Jul 17, 2024

BUY
$122.71 - $146.91 $17,670 - $21,155
144 Added 2.57%
5,756 $827 Million
Q1 2024

May 09, 2024

BUY
$102.11 - $135.92 $67,801 - $90,250
664 Added 13.42%
5,612 $719 Million
Q4 2023

Mar 14, 2024

BUY
$87.78 - $105.45 $434,335 - $521,766
4,948 New
4,948 $565 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $240B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Leo Wealth, LLC Portfolio

Follow Leo Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leo Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Leo Wealth, LLC with notifications on news.